Regulatory status by jurisdiction: difference between revisions
Diff·revision 10 → 11·22:08, 21 Mar 2025
Difference between revision 10 and revision 11 of Regulatory status by jurisdiction. 6 lines changed; the page grew by 114 bytes.
| Revision 10 — 15:25, 27 Feb 2025 DMF_Dermot (talk) add the note that this wiki does not give legal advice 3,277 bytes +556 | Revision 11 — 22:08, 21 Mar 2025 MolarMassMaeve (talk) add the telehealth prescribing point as attributed 3,391 bytes +114 | ||
|---|---|---|---|
| 38 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> | 38 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, ''Quality Attributes of Synthetic Peptide Drug Substances''.</ref> |
| 39 | 39 | ||
| + | 40 | == See also == | |
| + | 41 | * [[Personal importation policy]] | |
| + | 42 | * [[Customs seizure]] | |
| + | 43 | * [[Research use only]] | |
| + | 44 | * [[Grey market]] | |
| + | 45 | ||
| 40 | {{DEFAULTSORT:Regulatory status by jurisdiction}} | 46 | {{DEFAULTSORT:Regulatory status by jurisdiction}} |
| 41 | [[Category:Legal status by jurisdiction]] | 47 | [[Category:Legal status by jurisdiction]] |